Primeline Served With Petition for Dissolution
Tweet
Share
E-mailNot for distribution to the U.S. news wire services, or dissemination in the United States.
HONG KONG, July 26, 2024 (GLOBE NEWSWIRE) -- Primeline Energy Holdings Inc. (“Primeline” or the “Company”) announces that it has been served with a petition to the Grand Court of Cayman Islands, Financial Services Division by Shanghai Pudong Development Bank Co., Ltd., the agent for the syndicate of banks (the “Syndicate”) which provided the loan facility for finance of Primeline’s share of the development cost of the LS 36-1 gas field to Primeline’s subsidiaries, Primeline Energy China Limited (“PECL”) and Primeline Petroleum Corporation (“PPC”), for the winding up of Primeline on the grounds that Primeline is insolvent and unable to pay its debts as they fall due. As announced in its press release of May 2, 2024, Primeline had previously received notice of enforcement of its guarantee (the “Guarantee”) of the indebtedness of PECL and PPC from the Syndicate. As previously announced and as the Syndicate is aware, Primeline has no source of revenue or assets with which to repay the loan and meet its obligations under the Guarantee, in that production at LS 36-1 has been shut down. Primeline will therefore not oppose the winding up proceedings.
ON BEHALF OF PRIMELINE ENERGY HOLDINGS INC.
Signed “Andrew Biggs”
Chief Executive Officer
Contact:
Primeline Energy Holding Inc.
Andrew Biggs, CEO
PH: +44 207.499.8888
Fax: +44 560 372 5179
Toll Free: 1.877.818.0688
E-Mail: [email protected]
Please visit the Company’s website at www.primelineenergy.com.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Coastal Financial Corporation Announces CFO Transition
- York U awarded $2.5M to investigate, mitigate impact of increasing digital surveillance on refugees
- Ascletis Announces Oral Discussion of ASC36_35 FDC Preclinical Data Demonstrating Superior Weight Loss to Eloralintide/Tirzepatide Combination at the 62nd European Association for the Study of Diabete
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
